surmount-osa trial tirzepatide results Shows Benefit in Obstructive Sleep Apnea, SURMOUNT-5 (NCT05822830) was a multi-center,

Sofwave excels, because it only targets the skin, allowing for a more comfortable and safer treatment

In rodents, extensive in vitro and in vivo studies indicate that PYY (1-36) directly inhibits glucose-stimulated insulin secretion by activating Y1 receptors on -cells and -cells, while PYY (3-36) indirectly enhances insulin secretion by promoting GLP-1 secretion, thereby preventing -cell overactivation and functional exhaustion

Rationale for insulin management in gestational diabetes mellitus

The evidence base, such as it is, differs meaningfully across clinical targets, and it is worth examining each major application area on its own terms

Screening and identification of key biomarkers in nasopharyngeal carcinoma: evidence from bioinformatic analysis